Skip to main content
Premium Trial:

Request an Annual Quote

Doing Science Isn't Always About Doing Science

Doing science isn't always about going to the lab, creating experiments and researching new ways to cure cancer, DrugMonkey says. Sometimes it involves writing endless grant proposals and trying to secure new sources of funding. When he first began his life as a researcher, DrugMonkey says he wasn't at all concerned with his "career" and was more focused on "doing the science I wanted to do and following the steps" of grad school and a postdoc. Plus, the scientists he worked with didn't make a big deal out of what they had to do to secure funding for their labs, DrugMonkey adds. But now, that's part of what he does as well. Perhaps, he adds, "the system of NIH-funded research as we currently know it selects for a certain type of scientist. Perhaps there are going to be people who would otherwise make fine (superior?) lab heads and research team leaders who are screened out because of the whole grant game." But then again, DrugMonkey says, maybe researchers need to realize that the jobs they have are going to have aspects to them that are unpleasant, and that maybe they might come to tolerate and even enjoy some of these aspects. "And in the end analysis, like it or not, these things that you have to do are part of the job. Inextricable. And you have chosen to do this job. So you do the dirty bits along with the fun bits," he says.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.